Medication-delivering drones and telehealth at local libraries are among the ideas state leaders revealed in November for spending their share of a $50 billion federal rural health program. The Trump administration, which has promised “radical transparency,” said in an FAQ that it plans to publish the “project summary” for states that win awards. Following the…
On vacation in Mexico last year, Michael DiPlacido passed out twice while scuba diving and again in his hotel. Back in St. Louis, doctors diagnosed him with amyotrophic lateral sclerosis, or ALS, an incurable disease that often requires mechanical ventilation. When his son Adam DiPlacido tried to find a permanent place to care for his…
By JEFF GOLDSMITH This morning, after twelve years, I dumped my Medicare Advantage plan and enrolled in a Medicare Supplement policy. My smoldering discontent finally boiled over and . . . I’m gone. It was a large network style national plan with zero premium. My decision to enroll in MA was, in part, ideological. I liked the…
That is the news out of the UK today. A press release from the United Kingdom government states: A 25% increase in medicine pricing corresponds to 2 changes to the way NICE evaluates medicines; a change to the cost effectiveness thresholds and the introduction of a new value set for judging health states.NICE currently assesses value for money…
Experts emphasized that getting digital mental health support to underserved youth requires community partnerships, culturally tailored approaches, peer outreach and equitable access. The post How Do We Ensure Digital Mental Health Solutions Reach Underserved Youth? appeared first on MedCity News.
Regeneron Pharmaceuticals will share in development of Tessera Therapeutics’ TSRA-196, a Phase 1-ready gene-editing therapy for alpha-1 antitrypsin deficiency (AATD). Other companies developing genetic medicines for this rare disease include Beam Therapeutics, Wave Life Sciences, Korro Bio, and AIRNA. The post Regeneron Puts Up $150M to Partner on Tessera Gene-Editing Med for Rare Liver &…
This tracker provides data on global COVID-19 cases and deaths by country, region, and income-level. Additionally, the tracker reports current closure, economic, and health system policy responses to the COVID-19 pandemic globally. This tracker will be updated as new data are available.
Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by rising costs and a complex, opaque healthcare system. Kristin Wikelius of United States of Care said restoring confidence will require more transparency, simpler navigation and policies that prioritize preventive care. The post What Is Needed to…
The healthcare industry is contending with a difficult question: how to properly wield AI without taking on too much risk? Inherent in this battle is the role of humans. Here’s how Merck’s chief data officer is viewing AI. The post For Merck, AI Puts Humans In the “Right Room” appeared first on MedCity News.
Strategic planning for the upcoming measurement year should incorporate thorough communication between the health plan, its HEDIS vendor, and auditor. The post Building a Foundation for HEDIS Success Amid Change appeared first on MedCity News.